DexCom, Inc. DXCM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 275.10M | 249.10M | 199.50M | 267.30M | 283.80M |
| Total Depreciation and Amortization | 74.50M | 68.20M | 67.10M | 81.90M | 63.60M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.00M | 49.50M | 44.60M | 95.80M | 80.90M |
| Change in Net Operating Assets | -68.00M | -97.60M | 214.40M | -151.00M | 231.60M |
| Cash from Operations | 325.60M | 269.20M | 525.60M | 294.00M | 659.90M |
| Capital Expenditure | -52.90M | -84.70M | -76.60M | -101.90M | -80.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -41.20M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.80M | 455.70M | -221.90M | 408.50M | 273.30M |
| Cash from Investing | -76.70M | 329.80M | -298.50M | 306.60M | 192.80M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -1.21B | -- |
| Issuance of Common Stock | 12.00M | 0.00 | 12.70M | 0.00 | 13.90M |
| Repurchase of Common Stock | -401.60M | -605.40M | -35.80M | -312.80M | -187.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.90M | -1.90M | -1.90M | -1.90M | -1.70M |
| Cash from Financing | -391.50M | -607.30M | -25.00M | -1.52B | -175.00M |
| Foreign Exchange rate Adjustments | -1.10M | -4.90M | -2.80M | 3.80M | -1.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.70M | -13.20M | 199.30M | -917.80M | 676.60M |